Get the Stockscreener App
1.60
4.47%
-0.07
Serina Therapeutics Inc stock is traded at $1.60, with a volume of 67,976.
It is down -4.47% in the last 24 hours and down -35.41% over the past month.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
See More
Previous Close:
$1.67
Open:
$1.65
24h Volume:
67,976
Relative Volume:
0.06
Market Cap:
$17.21M
Revenue:
$144.00K
Net Income/Loss:
$-14.50M
P/E Ratio:
-1.1034
EPS:
-1.4501
Net Cash Flow:
$-14.95M
1W Performance:
-11.86%
1M Performance:
-35.41%
6M Performance:
-68.66%
1Y Performance:
-65.99%
1-Day Range:
$1.55
$1.66
1-Week Range:
$1.55
$1.81
52-Week Range:
$1.5341
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
Name
Serina Therapeutics Inc
Sector
Industry
Phone
(256) 327-9630
Address
601 GENOME WAY, HUNTSVILLE
Compare SER vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
1.5953 | 18.01M | 144.00K | -14.50M | -14.95M | -1.4501 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.31 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
763.61 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
722.13 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.36 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.71 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
Serina Therapeutics Inc Stock (SER) Latest News
Serina Therapeutics Advances SER-252 Parkinson’s Trial, Marking a Key Early Milestone for Investors - TipRanks
Entry Recap: Is Zillow Group Inc showing insider buying2025 Growth vs Value & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Serina Therapeutics Announces Dosing of First Patient in - GlobeNewswire
New drug SER-252 enters Phase 1b trial for advanced Parkinson's - Stock Titan
SER SEC FilingsSerina Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
Serina Therapeutics2026 Funding Rounds & List of Investors - Tracxn
Serina Begins Phase 1b Registrational Trial Of SER-252 In Advanced Parkinson's - Nasdaq
First patient enrolled in Serina’s Parkinson’s disease trial - Investing.com
Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease - The Manila Times
New Parkinson's trial enrolls first patient as Serina targets advanced disease - Stock Titan
SER PE Ratio & Valuation, Is SER Overvalued - Intellectia AI
Serina Therapeutics (SER) SVP awarded 69,000 stock options at $2.76 - Stock Titan
What are Serina Therapeutics Inc.’s recent SEC filings showingWeekly Loss Report & Fast Momentum Entry Tips - mfd.ru
Momentum Shift: Is CERo Therapeutics Holdings Inc likely to announce a buybackMarket Movers & High Accuracy Swing Trade Signals - baoquankhu1.vn
Aug Drivers: Whats next for Marchex Inc stockShort Setup & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Is Serina Therapeutics Inc. benefiting from interest rate changesTrade Performance Summary & Technical Entry and Exit Tips - mfd.ru
Will Serina Therapeutics Inc. stock outperform international peersJuly 2025 Big Picture & Expert Approved Momentum Trade Ideas - mfd.ru
Published on: 2026-02-05 05:58:49 - mfd.ru
Serina Therapeutics CSO sells $19,680 in shares By Investing.com - Investing.com South Africa
Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event - The Globe and Mail
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event - Finviz
Bull Bear: Is Serina Therapeutics Inc a stock for growth or value investorsTrade Entry Summary & Smart Swing Trading Techniques - baoquankhu1.vn
Stock Recap: Is Serina Therapeutics Inc a stock for growth or value investorsEarnings Performance Report & High Conviction Investment Ideas - baoquankhu1.vn
Serina Therapeutics Insider Sells $23K in Stock - National Today
Why did SER stock surge over 70% in pre-market today? - MSN
Bull Run: What are Serina Therapeutics Incs recent SEC filings showingMarket Growth Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
Serina Therapeutics CSO sells $23,185 in shares By Investing.com - Investing.com Canada
Serina Therapeutics CSO sells $23,185 in shares - Investing.com
Serina Therapeutics Stock Soars Amid Strategic Partnership Announcements - StocksToTrade
Serina Therapeutics Announces FDA Clearance of IND - GlobeNewswire
Serina Jumps On FDA's IND Clearance For SER-252 In Advanced Parkinson's Disease After Clinical Hold - Nasdaq
What Sparked Serina Therapeutics (SER) 35% After-Hours Surge? - Finviz
Serina Therapeutics stock soars after FDA clears IND for Parkinson’s drug By Investing.com - Investing.com South Africa
Serina Therapeutics stock soars after FDA clears IND for Parkinson’s drug - Investing.com UK
Serina Therapeutics announces FDA clearance of IND application for SER-252 for the treatment of advanced Parkinson's disease - marketscreener.com
Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s disease - The Manila Times
Serina Therapeutics, Inc. Announces FDA Clearance for SER-252 IND - TradingView
FDA clears trial of new advanced Parkinson’s therapy SER-252 - stocktitan.net
New Highs: Why is Serina Therapeutics Inc stock going upJuly 2025 Update & Weekly Breakout Stock Alerts - baoquankhu1.vn
Serina Therapeutics CSO sells $7375 in shares By Investing.com - Investing.com Canada
Aug Technicals: Is Serina Therapeutics Inc benefiting from innovation trends2025 Biggest Moves & Daily Growth Stock Investment Tips - baoquankhu1.vn
Serina Therapeutics CSO sells $12,140 in shares By Investing.com - Investing.com UK
Serina Therapeutics CSO sells $12,140 in shares - Investing.com
Geopolitics Watch: Why is Serina Therapeutics Inc stock going upTrade Risk Summary & Accurate Trade Setup Notifications - baoquankhu1.vn
Winners Losers: What is the dividend yield of Serina Therapeutics IncJuly 2025 Action & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Serina Therapeutics receives NYSE notification - MSN
Serina Therapeutics (SER) Receives NYSE Deficiency Notice for Low Stockholders' Equity - Intellectia AI
Serina Therapeutics Receives NYSE Deficiency Notice; Stock Edges Down - Nasdaq
Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity - The Globe and Mail
Serina Therapeutics receives NYSE listing deficiency notice - Investing.com
Serina Therapeutics Inc Stock (SER) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.07%
0.71%
Cap:
|
Volume (24h):